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Abstract 
The microbiota is a complex ecosystem of microbes, the bulk of which reside mainly in 
the colon, and has been shown to be significantly influenced by the diet. The biological 
functions of the microbiota have been strongly linked to health and disease, including 
the development of metabolic syndrome (MetS). The aim of this paper was to review 
current literature on the effects of the diet on gut microbiota in relation to the 
development of MetS through the following objectives: (i) to determine how the diet 
influences the composition and functions of the microbiota; (ii) evaluate evidence of 
how this is linked with development obesity and biomarkers of MetS; (iii) investigate the 
significance of diet-microbiota interactions in relation to obesity and MetS. Multiple 
databases were used to find and collate relevant literatures. The main findings highlight 
that a plant-based diet, rich in indigestible carbohydrate was strongly associated with a 
richer, more diverse microbiota profile compared to a high-energy, high-fat Western 
diet. Studies in mice have indicated that weight gain can be induced via inoculation of 
an obese-type microbiota without changes in dietary intake. Additionally, polyphenols 
appear to interact with the microbiota, producing metabolites which have shown to 
possess more health potential than their precursors. Unabsorbed polyphenols also 
seem to beneficially modulate the microbiota, resulting in positive health outcomes. 
More in vivo human studies are necessary to conclude the significance of the 
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microbiota and mechanisms of action in the development of MetS. With this knowledge, 
there may be potential to manipulate the gut microbiota toward the generation of 
desired health outcomes as an alternative to pharmaceuticals.  
Key words: microbiota, microbiome, metabolic syndrome, obesity, polyphenols, 
phytochemicals, dietary fibre 
Abbreviations:  
MetS – Metabolic syndrome; GI – Gastrointestinal; CHO – Carbohydrate; SCFAs – 
Short-chain fatty acids; AA – Amino acid; BCFAs – Branched-chain amino acids; TMAO 
– Trimethylamine-N-oxide; SFA – Saturated fatty acid; LPS – Lipopolysaccharide; 
LFHCC – Low-fat, high complex-carbohydrate; OM – Obesogenic microbiota; FMT – 
Faecal microbiota transplantation; GRP – G-protein-coupled receptor; PYY – Peptide 
YY; LGC – Low gene count; HBC – High gene count; GF – Germ-free; ANGPTL4 - 
Angiopoietin-like 4; LPL – Lipoprotein lipase; TJ – Tight junction 
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1. Introduction  
 
1.1 Composition of the gut microbiota  
The Human Microbiome project has been one of the major influential projects in 
contributing to current understanding of the gut microbiota (Segata et al., 2012). The 
microbiota is a highly complex ecosystem consisting of ~100 trillion diverse microbes, 
including yeasts, single-cell eukaryotes, viruses and parasitic worms (Bäckhed et al., 
2005), and is governed by age, diet, environment and the co-evolution of the gut 
microbes themselves (Ley et al., 2008).  The entire gastrointestinal (GI) tract is 
colonised with metabolically active microbes, but to varying degrees depending on the 
environment of the site; the colon harbouring the majority of bacteria found in the 
human body (Whitman et al., 1998). Studies have demonstrated that two bacterial phyla 
dominate the gut microbiota – Bacterioidetes (Gram-negative), and Firmicutes (Gram-
positive). While the human genome is comprised of approximately 22,000 protein-
encoding genes, the microbiome equates over three million unique protein-encoding 
genes, which can change rapidly thus resulting in metabolic, transcriptomic and 
proteomic modifications. The main functions of the microbiota include fermentation of 
indigestible food components; vitamin and amino acid synthesis; production of short 
chain fatty acids; metabolism of dietary toxins and carcinogens; conversion of 
cholesterol and bile acids and maturation of the immune system (Li et al., 2016). The 
relationship between the microbiota and human health appears to be bidirectional, 
rather than consequential, and there is also an environmental factor that affects the 
host metabolism and physiology. Current knowledge suggests that the composition and 
activity of the microbiota may influence early nutritional status, growth, energy balance, 
and individual susceptibility to infections and immune disorders throughout the lifespan 
(Agostoni & Kim, 2015).  
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1.2 Variation between individuals  
At lower taxonomic levels, the mammalian microbiota is highly variable across 
individuals (Dethlefsen et al., 2007). While it was once suggested that subjects could be 
grouped into one of three ‘enterotypes’, this has since been discredited, with well-
supported evidence of continuous gradients present across individuals (Knights et al., 
2014). On one hand, genetics appear to have less of an impact on gut microbial 
composition than diet - even twins typically share no more than fifty percent of bacterial 
species (Turnbaugh et al., 2010). On the other hand, the environment and close 
physical contact between individuals have shown to modify significantly the gut 
microbiota, with cohabiting family members sharing a similar composition (Song et al., 
2013).  Healthy individuals are generally associated with a high level of microbial 
diversity and richness compared to individuals in sub-healthy condition such as obesity 
(Le Chatelier et al., 2013, Cotillard et al., 2013). Many studies have demonstrated that 
dysbiosis - disruption or imbalances in normal microbial composition - is associated with 
many major diseases (Petersen & Round, 2014), including obesity (Turnbaugh et al., 
2006) and diabetes (Qin et al., 2012). It is assumed that higher levels of diversity within 
the gut helps better withstand stress and may help maintain stability due to competitive 
interactions (Coyte et al., 2015). The composition of the gut microbiota is dynamic and 
intra-individual variability over time does exist, although to a lesser extent than inter-
individual variation and on a species or strain-level (Costello et al., 2009). However, 
individuals may possess different bacterial species that are responsible for catalysing 
the same reaction. Therefore, taxonomic variability of the gut microbiota is greater than 
functional variability (Turnbaugh et al., 2009a). Microbial genes encoding a core activity 
will be present in every individual, forming a “functional core”, while other activities may 
be restricted to certain individuals (Matthies et al., 2009). The microbiota can be 
influenced by many external factors, but most significantly the diet. Dietary transition 
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through human history to the Western diet of today has resulted in substantial 
differences in the GI tract of humans though geographic differences have also been 
observed. 
1.3 Dietary plant constituents in relation to obesity and MetS 
Epidemiological studies have suggested a link between plant-based diets with reduced 
risk of diseases associated with metabolic syndromes (MetS), such as abdominal 
obesity, insulin resistance, hypertension and high cholesterol (Centritto et al., 2009). 
Phytochemicals, defined as the non-nutritive, naturally occurring chemicals found in 
fruits, vegetables, wholegrains, legumes, beans, herbs, spices, nuts and seeds, are 
responsible for producing physiological properties as well as protecting against various 
environmental stressors of the plant crops. Polyphenols are a particularly widely studied 
group of phytochemicals, representing the largest and most widely distributed group of 
phytochemicals, with more than 8000 currently identified (Tsao, 2010). Recent research 
suggests that the interaction between polyphenols and gut microbiota may influence 
health and protect against the development of MetS. 
Current strategies in control and management of the obesity epidemic focus on calorie-
restriction, lifestyle modification and use of pharmaceutical agents. Weight loss drugs 
on the market are costly, often with side effects including cardiovascular complications 
or even suicidal tendencies (Baboota et al., 2013). Antibiotics, while have demonstrated 
some benefits to microbiota modulation in relation to obesity, are not a realistic solution 
due to the impact on the normal microbiota and the potential for evolution of multi-drug 
resistant bacteria (Buffie & Pamer, 2013). Thus, the development of radical new 
treatments to curb the spread of chronic diseases across the world is essential.  
2. Materials and methods  
 
2.1 Data collection  
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Initial literature search commenced in October 2016. Literature from peer-reviewed 
journals and research papers were gathered from various databases such as Web of 
Science, Scopus and Medline. These databases were thought to be sufficient to fulfil 
the aims of this paper as they offer a broad range of current academic papers that are 
reliable and trustworthy, and allow efficient and specific searches to be carried out. 
Searches can also be refined or expanded by applying exclusion or inclusion criteria, 
assisting with finding papers that are most relevant to the project.  
 
2.2 Eligibility criteria 
 
Papers were screened in order to efficiently identify the most relevant and appropriate 
papers. Exclusion criteria firstly included sources not written in English, as this may 
affect the ability to fully understand the content of the papers. Papers were also refined 
to those published from the year 2000 onwards, as this representing the largest scope 
of relevant up-to-date papers.  Additionally, all papers were to relate to humans, 
excluding children, as this was deemed important for core papers in order to meet the 
aim. However, in some cases, in vivo animal studies were included where findings were 
deemed important. Final inclusion criteria included that full text must be available.   
 
2.3 Search Strategy  
 
Research commenced using keywords relevant to the topic, such as ‘microbiota’, and 
‘metabolic syndrome’. Each search was run through all three databases to ensure 
maximum coverage of relevant papers. The ‘AND’ function was utilised in order to 
refine and restrict searches, for example ‘microbiota ‘AND’ ‘metabolic syndrome’ whilst 
the ‘OR’ function was also used to expand searches when necessary or to combine 
variations of a keyword that mean the same thing, for example ‘microbiota’ ‘OR’ 
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‘microbiome’. Gaps in any information needed to fulfil the aims of the project resulted in 
further keyword searches, such as ‘AND’ ‘health’ OR ‘nutrition’. When relevant, the 
truncation symbol (*) was utilised, so as all derivatives from that term were included in 
the search. For example ‘gut micro*’ searched for gut microbes, gut microbiota and gut 
microflora. This ensured as many relevant papers were identified as possible. Final 
searches included ‘AND’ ‘metabolism’ OR ‘metabolic’, as well as ‘AND’ ‘energy 
absorption’ OR ‘nutrient absorption’, but resulted in very few relevant papers.  
According to Hierarchy of Evidence, meta-analysis, systematic reviews and critically 
appraised articles were regarded as the highest quality types of studies respectively, 
followed by randomised-controlled trials (RCTs), cohort studies, case-controlled studies 
and reports, and finally, expert opinion. This was considered useful, as more time was 
spent analysing and reviewing those papers deemed more valuable as a priority, over 
those which may be less scientifically significant. It also allowed a better understanding 
of the strength of the evidence or information being analysed, enabling better quality 
and validity of results (Figure 1). 
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Potential articles identified from online 
database search (n = 474) 
Titles and abstracts examined and compared   
(n = 62) 
Articles excluded based on titles and abstracts 
(n = 412) 
Articles excluded for repetition (n = 15) 
Papers saved and references examined 
Potential further articles identified from 
references of relevant articles (n=26) 
Papers identified for full text review 
(n=8) 
Full papers assessed in more detail 
Papers identified for inclusion in systematic 
review (n=25) 
Papers identified for inclusion in systematic 
review (n=33) 
Articles removed: 
 
Article not retrieved (n=7) 
Based on abstract (n=5) 
Duplicate (n=2) 
Repetition (n=3) 
Poor methodology (n=1) 
 
Articles removed: 
 
Article not retrieved (n=6) 
Children (n=3) 
Animal studies (n=3) 
Doesn’t address question (n=6) 
Not English (n=2) 
Lack of focused study question (n=2) 
 
Figure 1: Search Strategy  
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3. Results  
A total of thirty-three papers were included in the final core papers. The information 
within these papers was divided into four main codes (Figure 2) consisting of twenty-
two codes (Figure 3). Figure 4 depicts which types of paper were used in each theme. 
    Figure 2: The number of core papers correlating to each theme. From the core papers chosen, the 
themes ‘obese microbiota’ and ‘impact of dietary components’ collated the most information, as each was a 
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key concept in over 50% of the total.  The majority of information for the theme ‘healthy microbiota’ was 
collated from 17 core papers, and for ‘impact of types of diet’ was from 8 papers.  
Figure 3: The number of core papers correlating to each individual code within each theme. Within the 
theme ‘healthy microbiota’, composition represented the largest code, with 10 corresponding papers. 
Within the theme ‘impact of dietary components’, probiotics and prebiotics and antibiotics were the most 
common however were deemed less relevant to the aim of this paper compared to carbohydrate and 
phytochemicals, which were the next largest code (6 and 5 papers respectively). The western diet was the 
most represented code within the theme ‘impact of types of diet’ (6 papers). ‘Composition’ was the largest 
code within the theme ‘obese microbiota’ (10), followed by dysbiosis and inflammation (8) and energy 
harvest (7). 
Figure 4: Number and type of core papers correlating to each theme. The results indicate that reviews 
were the most used source for each theme. Experiment studies were used for three themes, in particular, 
the ‘obese microbiota’. Clinical trial core papers provided information for three of the identified themes. 
Randomised control trials were also used for all four themes, although typically they represented a smaller 
proportion of papers used for each theme. 
4. Discussion  
4.1 Establishment and development of the gut microbiota over the lifecycle 
 
While unborn infants were previously thought to be sterile, the demonstration of 
microbes in the placenta, amniotic fluid and umbilical cord blood suggests a window of 
opportunity may lie prior to birth. Particular areas of enhanced colonisation are during 
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birth, feeding and weaning. Factors such as stress, a prolonged pregnancy and use of 
antibiotics may also affect intestinal colonisation within the infant. By the age of three, 
the infant microbiota resembles that of an adult. Extensive studies have shown that 
while intra-individual variability does exist, the overall gut microbiota is stable 
throughout adulthood. Sixty percent of the taxa found in the microbiota of an individual 
is still present after five years, suggesting the concept of a “core” microbiome (Faith et 
al., 2013).   
However, the elderly exhibit significant levels of inter-individual variation, possessing 
higher numbers of pathogenic bacteria and lower levels of probiotic microbes such as 
Bifidobacterium. Therefore, while the adult microbiota is relatively stable, studies 
suggest that old age significantly impacts on the composition of the gut microbiota. 
Lifestyle and nutritional aspects may also play a role, with differences being observed 
between elderly individuals in long-stay care and those in community-living (Claesson 
et al., 2012). 
4.2 Major functions of the microbiota  
The host lives in symbiosis with their gut microbiota, but interactions range from 
mutualistic to parasitic. The microbiota performs many essential roles the human body 
otherwise cannot, and in its absence, nearly all aspects of host physiology are affected 
(Marchesi et al., 2016). Thus, the microbiota can be regarded as a somewhat forgotten, 
yet critically essential organ. 
The microbiota comes into contact with a wide variety of food components that escape 
upper gut digestion, namely complex indigestible carbohydrates (CHOs). Fermentation 
of indigestible CHOs and fibre is one of the main functions of the microbiota, while 
simultaneously providing the principle energy source for gut bacteria due to its enriched 
genes which are involved in CHO metabolism and uptake (Kurokawa et al., 2007). The 
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utilisation of these dietary components may represent ten percent of daily energy intake 
(Fernandes et al., 2014). Thus, the colon increases energy harvest from foods and 
plays a critical role in host metabolic functions (Tremaroli & Bäckhed, 2012), while 
influencing the bioavailability, synthesis and function of essential vitamins, minerals, 
macronutrients (He et al., 2013). Fermentation of dietary polysaccharides produces 
acetate, propionate and butyrate, highly bioactive short-chain fatty acids (SCFAs), and 
gases such as carbon dioxide and hydrogen. These SCFAs act as an energy source for 
colorectal tissues, colonocytes and bacteria, as well as signalling molecules and 
modulating intestinal metabolism and inflammation (Fernandes et al., 2014). Butyrate is 
regarded as beneficial for the host, promoting cell growth and acting as an anti-
inflammatory (Hamer et al., 2008). Acetate contributes to the synthesis of lipids and 
cholesterol within the body, while propionate can inhibit the function of acetate. 
Additionally, the microbiota also protects against opportunistic pathogens, directly 
preventing pathogens from attaching themselves to the host, as well as maintaining 
appropriate intestinal pH and outcompeting pathogens for nutrients. The microbiota also 
assures the establishment and maturation of the immune system and converts bile 
acids and cholesterol (Laparra & Sanz, 2010).  
Conversely, the microbiota also possesses the ability to contribute towards chronic, 
metabolic and infectious diseases, as well as malnutrition. The microbiome and host 
genome differ, thus can either work in cooperation, or in conflict. Access to resources, 
such as food, may be foundation in shaping the interaction between microbiota and the 
host – for example – unlike fibre, simple carbohydrates can be used by both host and 
microbiome, thus competition arises over access to this nutrient, which can result in 
inflammation and adverse compositional changes in the microbiota (Wasielewski et al., 
2016). 
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4.3 Interaction between dietary components and the microbiota  
4.3.1 Carbohydrate (CHO) and dietary fibre 
CHO fermentation is the preferred energy source for the gut microbiota, which largely 
occurs in the proximal gut i.e. colon which contains the highest concentration of 
substrate availability (Figure 5). The amount of dietary CHO that comes into contact 
with the colon depends on many factors, such as meal size, chemical structure, food 
matrix and bolus, processing and preparation method (e.g. cooking), food form (e.g. 
whole food), rate of digestion and gut transit and the presence of enzyme inhibitors 
(e.g. tannins) (Cummings & Stephen, 2007). Foods that retain their structure throughout 
ingestion, such as wholegrains, protects CHOs from digestion in the small intestine, 
allowing a larger proportion to reach the colon. Here, they can be metabolised within 
the gut microbiota, providing an important source of CHO. The main CHOs for bacterial 
fermentation in the colon include indigestible CHOs such as polysaccharides, 
oligosaccharides and resistant starch and fibre.  
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Figure 5: Progression of food through the gastrointestinal tract. Total SCFA concentration is highest in the 
proximal colon and decreases as the stool progresses along the colon due to their absorption. Due to this, 
along with progressive depletion of CHO substrates and increased protein fermentation, pH progressively 
increases from proximal to distal colon (Illustration created based on information of Windey et al.,2011).   
Certain bacterial species are associated with CHO consumption. For instance, a 
decrease in consumption of CHO in obese subjects results in a progressive reduction of 
Bifidobacterium (Hold et al., 2003). Studies observing the impact of resistant starch on 
the microbiota composition have demonstrated that different type of resistant starch 
produces various results depending on the type of glycosidic linkage in the food and the 
functional capability of the gut microbes (Koropatkin et al., 2012).  
Foods rich in fibre are recognized to protect against overweight and obesity, and related 
diseases. There are clear epidemiological links between a diet high in fibre and 
improved MetS and reduced body weight, and a preventative and therapeutic effect of 
fibre on many disorders of the colon (Tuohy et al., 2009). Subjects consuming a high 
fibre diet have shown to produce stools with a decreased pH compared to those on a 
low-fibre diet, which is associated with a higher production of SCFAs and subsequently, 
better regulation of intestinal bacterial community and reduced growth of pathogenic 
bacteria (Walker et al., 2005).  
4.3.2 Protein and amino acids (AAs)  
Dietary protein provides colonic microbes with nitrogen for growth, absorption of CHO 
and production of SCFAs. It has been demonstrated that factors such as heat-
processing, the food matrix, quantity ingested and the presence of compounds 
inhibiting proteolysis will influence the amount of dietary protein in the colon. While 
CHO fermentation is favourable, AA fermentation may occur in the event of CHO 
exhaustion either sourced from food or endogenous sources. There is substantially less 
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protein that reaches the colon compared to CHO, but as CHO is diminished during 
transit along the colon, AA fermentation begins to take over, resulting in a large range 
of metabolites and gases, such as amines, phenols, hydrogen sulphide, branched-chain 
fatty acids (BCFAs), ammonia and N-nitrous compounds, many of which are potentially 
cytotoxic, genotoxic or carcinogenic to human cells (Kovatcheva-Datchary et al., 2009). 
Whether protein is beneficial or harmful for microbial health in the colon depends on the 
type of dietary protein and the interaction with other dietary components. For example, 
consumption of red meat is associated with higher concentrations of trimethylamine-N-
oxide (TMAO), a microbial metabolite of L-carnitine, which may increase risk of 
atherosclerosis (Koeth et al., 2013). High protein, low CHO diets have shown to result 
in decreased production of butyrate and Bifidobacterium levels compared with high 
CHO and fibre, low-fat diet (Brinkworth et al., 2009).  
Studies demonstrate that the amount of dietary protein consumed directly correlates 
with the amount of AA metabolites produced (Conlon & Bird, 2014), however, this is 
inconsistent across studies. Most ammonia for example, while potentially toxic, is 
excreted in the urine or faeces. Shoaie et al. (2015) demonstrated that obese 
individuals with low microbiome richness had elevated levels of certain AAs, such as 
phenylalanine and other branched-chain AAs, which are associated with T2D and 
insulin resistance. Diets promoting microbial protein synthesis that is associated with a 
richer microbiome, are better by means of converting AAs, excreting more nitrogen into 
the faecal stream, thus reducing plasma concentrations of nitrogen (Kramer et al., 
2012). This indicates other dietary constituents are also important in influencing how the 
microbiota responds to dietary protein.   
4.3.3 Dietary fat & bile acids  
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The small intestine typically absorbs ninety-five percent of dietary lipids (Hinsberger & 
Sandhu, 2004). However, the rest often comes into contact with the colon. The effect of 
dietary fat on the gut microbiota is thought to be largely influenced by bile acids. Bile 
acids are steroids found within bile and conjugated with glycine by the enzyme 
cholesterol 7α-hydroxylase in the liver to form bile salts. Primary bile acids are 
synthesised in the liver (De Aguiar-Vallim et al., 2013), while secondary bile acids are 
produced by gut microbes from primary bile acids by 7 α-dehydroxylation (Ou et al., 
2012). A high animal-fat diet has shown to increase the amount of bile acids which 
escape the SI and enter the colon and are subsequently available for microbial 
metabolism. The presence of bile acids in the colon seems to exert strong selective 
pressure, with only microbes being able to withstand bile acid conditions and to survive, 
thus restricting the growth of many microbes (Kurdi et al., 2006). Secondary bile acids 
are pro-inflammatory and may be carcinogenic and involved in the development of 
disease of the GI tract. However, they can also inhibit colonisation of certain pathogens, 
such as Clostridium difficile (Buffie et al., 2015). Therefore, the regulation of hydrolysis 
of primary bile acids into secondary bile acids needs to be further understood.   
Importantly, the type of fat may have vastly different effects on the microbiota. It is 
accepted that unsaturated fat can benefit circulatory health, and studies have also 
demonstrated that it may protect against weight gain (Caesar et al., 2015). This is an 
unsurprising finding which may highlight the effects of fat on microbial metabolic activity 
and subsequently on host health, however, this needs to be further investigated.  
Conversely, saturated fatty acids (SFAs) have the ability to provide membrane 
substrates for pathogens such as E. coli, subsequently reducing bacterial energy 
requirements, promoting its survival (Yao & Rock, 2015).  
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High-fat diets and those high in emulsifiers, for example in processed food, may also 
thin the mucus barrier, which protects the epithelium from colonisation and invasion 
from pathogens, this contributing to a less favourable composition in the microbiota 
(Wasielewski et al., 2016). 
 
4.4 Impact of different diets on the microbiota 
Evidence that rapid dynamic changes (over 24-48 hours) can take place in the 
microbiota in response to dietary changes. Gut microbes are extensively purged every 
one to two days and have the ability to double in number within the space of an hour. 
This is demonstrated by several dietary intervention studies, which produce 
reproducible and significant shifts the microbiota that can overcome interpersonal 
variation in extreme cases. However, the shifts in response to daily variation in the diet 
are at the genus and species level, rather than at the phylum level. Additionally, the 
subject’s microbiota tends to revert back to the state prior to the intervention, 
suggesting that long-term diet is the primary driver in determining one’s gut microbiota 
(Xu & Knight, 2015). 
4.4.1 Palaeolithic diets and an evolutionary mismatch 
The rapid simplification of the diet since industrialisation has occurred at a much faster 
rate than the human genome can possibly adapt. Bengmark (2013) reports that the 
human microbiome is not dissimilar in fact to our palaeolithic forefathers living 200,000 
years ago, despite a vastly different diet. This adaptive lag is hypothesised to be central 
to many of today’s diseases, such as heart disease and obesity (Eaton et al., 2002). It 
is argued by many that it is unlikely that neither the human genome, nor the 
microbiome, will ever adapt to the Western diet (Carrera-Bastos et al., 2011), and that 
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humans will always be genetically programmed to consume a diet much more similar to 
that of Paleolithic times, rather than the modern diet.   
4.4.2 Western diets 
Low microbial genomic richness is generally observed in those consuming a Western 
diet, which is a potential contributing factor to associated disorders, such as MetS (Le 
Chatelier et al., 2013). This sub-optimal microbiota is likely due to a depletion of 
metabolic fuels, and can lead to dysbiosis, malfunction and increased plasma endotoxin 
levels. Subjects consuming a Western diet demonstrated a seventy-one percent 
increase in concentrations of endotoxin in plasma (endotoxemia) compared to controls 
(Pendyala et al., 2012), suggesting a disruption of intestinal barriers and increase in 
Gram-negative bacteria in the microbiota (Haro et al., 2016). These are in turn 
associated with inflammation and risk of development of chronic disease (Bengmark, 
2013). A high-energy diet, whether from fat or CHO, in mice has shown to result in 
increased levels of lipopolysaccharides (LPS), which are the components of endotoxins 
and gram-negative bacteria, and may be responsible for certain biological activity such 
as inducing inflammation. A high-fat diet has also been found to produce a stronger 
response compared to high-CHO (Pussinen et al., 2011). These indicate that 
overconsumption of energy can disrupt intestinal barriers, causing inflammation, and 
counteract the otherwise beneficial effects seen with consumption of indigestible CHO. 
 
One study switched humanised mice from a low-fat, high-CHO, plant-based diet to a 
typical Western diet high in fat and sugar and observed a reduction in Bacteroidetes 
(Turnbaugh et al., 2009b). The principle findings of a study conducted by Haro et al. 
(2016) in twenty obese adult men were an increased abundance of Prevotella and 
decrease in Roseburia following consumption of a low-fat, high complex-carbohydrate 
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(LFHCC) diet, compared to an increase in Roseburia and Oscillopira following 
administration of a Mediterranean style diet. Correlation analysis between individual 
diet-induced changes in bacterial genera and species and individual diet-induced 
changes in metabolites showed that the changes in seven metabolites in faeces and 
three metabolites in plasma were related to the changes in three bacterial genera and 
two bacterial species.   It is projected that the increase in Prevotella in the LFHCC may 
enhance ability to harvest energy from resistant starch and oligosaccharides and other 
CHOs that escape SI digestion. These studies suggest that compositional changes 
occur within the microbiota due to diet, which can result in metabolic shifts, with more 
energy extracted from food and therefore available for the host. However, this finding 
appears to run in contrast to the work indicating LFHCC diets lead to a more beneficial 
microbiota, thus complicating these findings. The LFHCC subjects also showed 
elevated butyrate-producing F.prausnitzii, which is negatively associated with T2D 
inflammatory biomarkers (Furet et al., 2010). The anti-inflammatory effect may in part 
explain why the LFHCC diet does not necessarily lead to increased weight gain despite 
increased energy harvest. 
4.4.3 Vegetarianism and veganism 
 Herbivores show enriched concentrations of enzymes involved in biosynthesis of AAs 
and a more diverse microbial community compared to carnivores, who show higher 
numbers of enzymes responsible for branched-chain AA degradation (Muegge et al., 
2011). In human participants, it has been observed that fat and protein from animal 
sources, compared to a high-CHO plant-based diet, decreased microbial diversity and 
richness (Wu et al., 2011). Many human studies, however, remain inconclusive in this 
area, with conflicting results reported. For example, where one study reported high 
concentrations of several Clostridium clusters associated with strict vegetarians, 
another reported lower proportions of Clostridium in vegetarians compared to meat-
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eaters (Zimmer et al., 2012). More large-scale studies under more similar conditions 
may improve the consistency of findings.  
Subjects consuming a vegan or vegetarian diet have displayed a lower stool pH 
compared to controls, limiting growth of E. coli in the gut. As previously discussed, red 
meat intake is also associated with increased concentration of plasma TMAO, which is 
dependent of specific gut microbes and linked to an increase of Prevotella. The 
microbiota of vegetarians and vegans, in contrast, are poor producers of TMA, which is 
required for oxidisation into TMAO, even when precursor compounds are temporarily 
incorporated into the diet (Koeth et al., 2013). Diets higher in animal proteins also tend 
to increase sulphur compounds in the microbiota, compared to plant-based diets which 
are higher in methane; however, the significance of this is not yet quantified (Magee et 
al., 2000). Contrasting results in human studies have also been observed in terms of 
microbial diversity between vegetarians and omnivores, some reporting that 
vegetarians have increased diversity and no difference being observed in others; 
however, it is usually agreed compositional changes certainly exist. The changes in 
microbiota composition may, therefore, play a role in the beneficial health effects 
associated with a more plant-based diet and lower intake of animal products.   
4.4.4 Other diets 
Interestingly, a gluten-free diet in healthy subjects showed a reduction in microbial 
communities generally regarded as beneficial for the host, such as Bifidobacterium and 
Lactobacillus, with an increase in E. coli and other opportunistic pathogens (De Palma 
et al., 2009). This may be explained by a lower intake of polysaccharides as an energy 
source and prebiotic for beneficial bacteria. This hypothesis has been tested by 
administration of a gluten-free, but high polysaccharide diet (Sanz, 2010).   
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The genome of the gut microbe Bacteroides plebeius in Japanese communities, where 
consumption on uncooked seaweed is common, has shown to retain β-porphyrase, an 
enzyme capable of digesting algal cell calls (Hehemann et al., 2010). This is not 
observed in most other communities. The evidence, therefore, supports the hypothesis 
that to a certain extent, the composition and functions of the microbiota co-evolves with 
the host and can adapt to specific macronutrients and to suit the requirements of the 
host depending on dietary intake. Personalised response to foods is imperative in 
understanding why it is unlikely that one diet or dietary component will tailor to all 
needs, or affect all populations in the same manner (Zeevi et al., 2015). 
Therefore, it is evident from current knowledge that dietary components consumed and 
the type of diet as a whole have the capacity to positively or negatively impact the 
compositional profile of the microbiota, potentially contributing towards the development 
of MetS.  However, these must be investigated further to consolidate current findings 
and to assess their relevance to the current incidence of MetS. The findings seem 
coherent with current knowledge on dietary factors known to be associated with the 
development of, or protection against, MetS. The interplay of the microbiota, therefore, 
may be yet another layer of complexity to the story which should be considered when 
regarding MetS aetiology.  
4.5 The association between the microbiota, obesity and MetS  
While the main cause of obesity is an excessive energy intake, the wide variation 
between individuals in microbiota composition and energy-harvest abilities may 
highlight the complexity of the development and treatment of obesity and associated 
diseases. Potential associations between the gut microbiota and obesity relate to 
energy balance, glucose metabolism and low-grade inflammation. 
4.5.1 Features of the obese-type microbiota  
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The commensal bacteria within the microbiota appears to be of importance in weight 
gain and fat storage. Differences in the relative abundance of Bacteroidetes and 
Firmicutes in obese and lean individuals seem to be the most commonly reported.  
Studies have demonstrated that there was an enhanced abundance of Firmicutes and 
reduced Bacteroidetes abundance in the microbiota of obese mice (Ley et al., 2005). 
This association was later observed in obese human subjects during a dietary 
intervention study. Furthermore, there appeared to be an increase in Bacteroidetes 
following weight loss (Ley et al., 2006). This ratio of Firmicutes and Bacteroidetes is 
also observed in T2D patients (Larsen et al., 2010). However, this association remains 
controversial, with other studies reporting the opposite effect or no significant changes 
(Collado et al., 2008; Duncan et al., 2008). Lower taxonomic changes have also been 
observed, and this may be a more accurate dysbiosis associated with obesity, however, 
as of yet, findings are complex and may be within the species-, rather than genera-level 
(Million et al., 2012). 
The obesogenic microbiota (OM) is believed to be inflammatory and show lower levels 
of bacterial richness and diversity. Pathways for the production of SCFAs are elevated 
in obese and overweight subjects, thus increasing the amount of fermentable 
substrates and calories available for the host. The OM also appears to have a lower 
potential for butyrate production and induce weight gain via modifying gene expression 
involved in absorption of dietary CHO and fat (Bӓckhed et al., 2004).  
The OM has displayed an enhanced capacity for energy harvest from the diet, a feature 
which appears to be transmissible as demonstrated by faecal microbiota transplantation 
(FMT) studies. SCFAs also act as signalling molecules which influence energy intake 
and metabolism, binding to G-protein-coupled receptors (GRP) 41 and 43 (Conterno et 
al., 2011). Activation of GRP41 and GRP43 by SCFAs induces the release of 5-
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hydroxytryptamine (5-HT) and peptide YY (PYY), increasing colonic mobility and 
efficiency of energy harvest (Samuel et al., 2008). The release of PYY in the plasma 
induces feelings of satiety (Delzenne et al., 2011). Thus, production of SCFAs may 
reduce appetite and help regulate food intake. 
4.5.2 Significance of microbiota richness and diversity  
Shoaie et al (2015) observed that obese individuals with low gene count (LGC) within 
the microbiome demonstrated an impaired metabolic phenotype compared to subjects 
with high gene count (HGC), such as poor glucose homoeostasis and insulin 
resistance. HGC subjects also produced higher levels of SCFAs important for 
metabolism and providing energy for beneficial microbes and colonocytes. Other 
studies have demonstrated that obese individuals with LGC showed improvements in 
gene richness following diet-induced weight loss associated with improved metabolism, 
highlighting the significance of a HGC and diversity in metabolic health (Sonnenburg & 
Bӓckhed, 2016; Cotillard et al., 2013). 
4.5.3 Studies in germ-free mice and faecal microbiota transplant 
The discovery that conventional mice store forty-two percent more body fat and forty-
seven percent more gonadal fat than germ-free (GF) mice, despite lower food intake, 
sparked the beginning of investigations on the microbiota as a potential factor 
influencing obesity. Subsequent studies have demonstrated that colonisation of GF 
mice with gut microbiota from conventional mice resulted in a sixty percent increase in 
body fat and increased levels of insulin resistance, adipocyte hypertrophy and 
circulating leptin and glucose. Partly, this is due to the ability of the microbiota to 
ferment indigestible polysaccharides, which can be absorbed as monosaccharides and 
increase hepatic lipogenesis.  In addition, colonisation of a gut microbiota in GF mice 
suppresses intestinal expression of angiopoietin-like 4 (ANGPTL4), an inhibitor of 
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lipoprotein lipase (LPL) and subsequently, this leads to increased uptake of fatty acids 
(Bӓckhed et al., 2004). Others have repeated similar studies, inoculating GF mice with 
the microbiota of either obese mice or obese humans, resulting in weight gain and 
increased accumulation of fat without changing dietary pattern or energy intake (Cox et 
al., 2014) quite possible due to an enhanced capacity for energy harvest from the diet. 
In fact, GF mice seem to be protected against diet-induced obesity even when fed a 
high-fat, high-sugar diet (Bӓckhed et al., 2007), with better insulin sensitivity and 
glucose tolerance compared to conventional mice fed the same diet (Rabot et al., 
2010). Transplant of the microbiota of lean subjects into subjects with MetS via FMT 
showed to improve insulin sensitivity and increase microbiota diversity and abundance 
of Roseburia intestinalis, subsequently increasing butyrate concentrations in stools 
(Vrieze et al., 2012). Studies have demonstrated that lean phenotypes are also 
transmissible via inoculation, reversing weight gain induced by introduction of an OM 
into GF mice (Ridaura et al., 2013). Therefore, this may be some of the most convincing 
evidence of a causal relationship between gut microbiota and excessive weight gain, or 
at least that the microbiota certainly plays a role. However, results following inoculation 
with a lean phenotype were diminished if fed a diet high in saturated fat and low in fruit 
and vegetables, highlighting that although microbiota composition is a reflection of the 
individual, the importance of the diet on its function.  
4.5.4 Low-grade inflammation and intestinal permeability  
Obesity and the development of MetS are associated with low-grade inflammation, 
which has been linked to excess circulating LPS. LPS is produced continually in the 
colon via degradation of gram-negative bacteria. As previously discussed, endotoxemia 
is associated with a Western diet, and continuous low-rate infusion of LPS has also 
been linked with excessive weight gain, hyperglycaemia and insulin resistance in mice 
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studies (Harte et al., 2010; Creely et al., 2007). In addition, mice injected with LPS 
showed an increase in weight and insulin resistance. In contrast, mice lacking LPS 
receptors were shown to be protected against MetS following infusion of LPS or 
administration of a high-fat diet, suggesting a causal link to LPS and LPS-receptors with 
obesity and MetS. Furthermore, Bifidobacterium, often shown to be reduced in obese 
subjects, has shown to be negatively correlated with concentration LPS and 
endotoxemia (Cani et al., 2007), which could, therefore, be another explanation for 
increased levels of inflammation observed in obese individuals.Evidence has shown 
that intestinal barrier function is largely controlled by tight junctions (TJs), and is 
important for protecting against pathogens and food antigens (Menard et al., 2010). 
4.6 Effect of dietary plant constituents on the microbiota   
4.6.1 Bioavailability and their metabolites in the microbiota 
A wide variety of functional components within plant species have been suggested to 
effect on microorganisms either directly or indirectly (Gyawali and Ibrahim, 2021). 
Previous work on polyphenols, one of the major dietary plant constituents, focused on 
the effect of native compounds, which demonstrated poor absorption and bioavailability 
and rapid elimination from the body. However, biological functions still existed, raising 
doubt as to the relevance of these studies. Growing evidence suggests that their 
metabolites may be more biologically active and proposed health effects may therefore 
be based on their bioavailability and metabolites produced (Delmas et al., 2011). As 
humans cannot effectively digest plant cell walls, this may be a mechanism by which 
phytochemicals can make it to the gut microbiota. Only ten per cent of polyphenols are 
absorbed within the SI into the blood (Clifford, 2004), while the ninety percent of non-
digested phenolics that reach the colon undergo extensive transformation by specific 
components within the gut microbiota (Scalbert et al., 2002).  The evidence that 
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metabolites are produced by microbial action has been shown in several studies, 
demonstrating a lower bioconversion in subjects administered antibiotics prior to 
flavonoid consumption and from the lack of polyphenol metabolites detected in germ-
free rats (Possemiers et al., 2011).  
4.6.2 Effects of polyphenols on microbiota function and composition  
Unabsorbed dietary polyphenols and their metabolites have shown abilities to modulate 
the gut microbiota, exerting stress or stimulus effects. The main benefit of polyphenols 
in modulating the microbiota is thought to be due to their antimicrobial effect. Phenolic 
compounds derived from tea have demonstrated inhibitory effects on both the growth 
and adhesion of pathogenic bacteria, such as Clostridium spp., E. coli and Salmonella 
typhimurium, while promoting proliferation and adhesion of beneficial bacteria, such as 
Lactobacillus or Bifidobacterium (Gyawali & Ibrahim 2012; Lee et al., 2006). Thus, the 
antimicrobial effect of polyphenols appears superior to that of antibiotics, which reduce 
beneficial, as well as harmful bacteria. Such selective bactericide effect has also been 
demonstrated across several studies with different phenolic compounds (Krogius-
Kurikka et al., 2009). For example, oxalic acid and phytic acid appear to bind to iron, 
thus microorganisms requiring iron for growth, such as pathogens, are outcompeted by 
microorganisms not requiring iron for growth (Gyawali & Ibrahim, 2012). Polyphenols 
were found to be able to reduce concentrations of pathogenic bacteria while increasing 
beneficial microbe populations. Therefore, polyphenols appear to modulate the 
composition of the microbiota towards a more beneficial profile, which would 
subsequently benefit host health.  
Phenolics have been proposed as a novel therapeutic strategy in the prevention of 
obesity and MetS via microbial modulation and prevention of dysbiosis in the 
microbiota. Quercetin and resveratrol treatments have shown to reduce fat 
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accumulation and weight gain in some studies, but not others (Mosele et al., 2015). 
Further studies in this area are necessary to pinpoint other mechanisms of action of 
polyphenol metabolites in relation to the development of MetS. A brief overview of the 
main interactions between the microbiota and polyphenols is depicted in Figure 6. 
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Figure 6: Diagram to show a summary of the main interactions between the microbiota and polyphenols
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5. Conclusion 
While understanding of the microbiota has advanced significantly, many studies show 
contrasting results or are inconclusive and with this being further complicated by the 
heterogeneity observed across individuals and the complexity and variation in the diet. 
However, it appears that a plant-based diet rich in indigestible CHO is associated with a 
healthy microbiota profile, while the Western diet, excessive in energy, high in fat and 
red meat, and low in fruit, vegetables and dietary fibre, is associated with dysbiosis and 
a less favourable gut microbiota. Most studies are consistent in suggesting that an 
obese-type microbiota is enriched in Firmicutes and reduced in Bacteriodetes, with a 
lower overall abundance and diversity and enhanced capacity for energy harvest and 
inflammation.  
Research has demonstrated that the polyphenol metabolites produced by the gut 
microbiota are more biologically active than their precursors. Unabsorbed polyphenols 
have shown to exert specific antimicrobial effects within the microbiota, inhibiting the 
growth of pathogens without affecting, or even stimulating, the growth of commensal 
bacteria, thus beneficially modulating the gut microbiota. Therefore, the microbiota 
seems to positively respond to dietary polyphenols, although changes appear to be at 
class-, family-, genus- and species-level rather than at phylum-level. It is likely that 
many positive effects exerted by polyphenols are not due to just one group, but of 
multiple biological activities from a range of metabolites.  
6. Future Perspectives 
More in vivo human studies are necessary to better understand the significance of this 
complex ecosystem in the development of MetS. With this knowledge, there is the 
potential to manipulate the gut microbiota to generate desired shifts in microbial 
populations and health outcomes.  
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